Advertisements

Neurosurgery Blog

0

Neoadjuvant anti-PD-1 immunotherapy promotes a survival benefit with intratumoral and systemic immune responses in recurrent glioblastoma

Neoadjuvant anti-PD-1 immunotherapy promotes a survival benefit with intratumoral and systemic immune responses in recurrent glioblastoma Nature Medicine – Article | Published Timothy F. Cloughesy,  Aaron Y. Mochizuki,  Joey R. Orpilla,  Willy Hugo,  Alexander H. Lee, ...

Advertisements
0

Radiosurgery as Primary Management for Acromegaly

Radiosurgery as Primary Management for Acromegaly Hugh P. Sims-Williams; Kaveesha Rajapaksa; Saurabh Sinha; Matthias Radatz; Lee Walton; John Yianni; John Newell-Price Clin Endocrinol. 2019;90(1):114-121. Objective: Transsphenoidal surgery (TSS) remains the recommended primary treatment for acromegaly. Long-term...